Drugs / brostallicin
brostallicin
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00060203 | Dec 2002 → Mar 2003 | plasma cell myeloma | Case Comprehensive Cancer Center | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT01091454 | Jun 2010 → Jun 2012 | triple-negative breast carcinoma | Alliance for Clinical Trials in Oncology | Completed | No outcome recorded |
| Phase 2 | NCT00633165 | Aug 2007 → Oct 2008 | myxoid liposarcoma | Systems Medicine LLC | Unknown | No outcome recorded |
| Phase 2 | NCT00410462 | Oct 2006 → Sep 2008 | ovarian cancer, sarcoma, small intestine cancer | European Organisation for Research and Treatment of Cancer - EORTC | Unknown | No outcome recorded |
| Phase 2 | NCT00041249 | May 2002 → Jan 2004 | gastrointestinal stromal tumor, soft tissue sarcoma | European Organisation for Research and Treatment of Cancer - EORTC | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | brostallicin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01091454 ↗ |
| Known as | Brostalicina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1189025 ↗ |
| Known as | Brostallicine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1189025 ↗ |
| Known as | PNU-166196A | “Randomized Phase II Study of Brostallicin (PNU-166196A) Versus Doxorubicin as First Line Chemotherapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma” NCT00410462 ↗1“A Phase I/II Study of the Safety and Efficacy of Brostallicin (PNU-166196A) in Adult Patients With Multiple Myeloma That Has Progressed on Prior Chemotherapy” NCT00060203 ↗ |
| Modality | Other / unclassified | “The study aimed to assess the efficacy and safety of brostallicin, a new DNA minor groove binder” PMID 17095209 ↗ Nov 2006 |
| Route | Intravenous | “intravenous (i.v.) every three weeks” PMID 17095209 ↗ Nov 2006 |